Physician profile
David C Markel
NPI 1689644023
$1,472,075.59
in general payments reported to CMS, 2019-2025
9 companies · $364K in 2025
The $364K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242K · 2020: $91K · 2021: $102K · 2022: $68K · 2023: $190K · 2024: $415K · 2025: $364K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $468K · Consulting Fee: $401K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $52K · Travel and Lodging: $38K · Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $467,730.70 |
| Consulting Fee | $400,525.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $51,625.00 |
| Travel and Lodging | $38,369.55 |
| Food and Beverage | $10,655.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $923,181.07 | 2019-2025 | Journey II, Real Intelligence, Journey |
| Stryker Corporation | $547,197.34 | 2019-2025 | Mako, Triathlon, Insignia |
| Encore Medical, Lp | $896.50 | 2022-2025 | Djo Surgical |
| Next Science LLC | $350.87 | 2023-2025 | Blastx, Xperience, Surgx |
| Heron Therapeutics, INC. | $139.83 | 2024-2025 | Zynrelef |
| Zimmer Biomet Holdings, INC. | $113.86 | 2023 | |
| C2dx, INC | $96.23 | 2022 | |
| Biocomposites INC | $63.56 | 2019 | |
| Avanos Medical | $36.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Markel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.